Home›Stocks›AARD

AARD — structural market context

Aardvark Therapeutics, Inc. Co

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 21. Each line shows the earlier value, the later value and their dates.

Price

Close $4.41 (Oct 21) vs $3.90 (Oct 20): +13.08%.

Volume

1.87× its 20-session average (117K) on Oct 21.

Includes pre- and post-market trading.

Short interest

Short interest 474K shares (settlement Sep 30) vs 425K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Insider filings (Form 4)

None recorded in this window.

AARD short interest & days to cover

SHARES SHORT
474K
% OF FLOAT
4.3%
DAYS TO COVER
5.3
CHANGE VS PRIOR
+11.6%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (22d ago)

AARD fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-31 · 52d841$5.79
2026-08-26 · 57d334$7.25
2026-08-19 · 64d75$6.15

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

AARD insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 2 sales

InsiderTypeSharesValueFiled
Sun Nelson · officer: See RemarksSale (S)15K$74K2026-09-11
Sun Nelson · officer: See RemarksSale (S)62K$321K2026-09-11

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is AARD's short interest?
As of the FINRA settlement date 2026-09-30, AARD had 474K shares sold short — 4.3% of its float, with 5.3 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying AARD?
In the last 12 months of SEC Form 4 filings, AARD recorded 0 insider purchases and 2 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell AARD?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with A

AA · Alcoa CorporationAADX · Applied Aerospace & Defense, IAAPG · Ascentage Pharma Group InternaAAPL · Apple Inc.AAUC · Allied Gold CorporationAAVMY · ABN AMRO BK N V AMSTERDAM BRHAll A →

AARD: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.